Environmentally regulated genes of Streptococcus suis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S165100, C424S184100, C424S185100, C424S244100, C424S278100, C930S010000, C930S200000

Reexamination Certificate

active

07927605

ABSTRACT:
The invention relates to the field of the diagnosis of and vaccination against Streptococcal infections, and to the detection of virulence markers of Streptococci. The invention discloses a method for modulating virulence of aStreptococcuscomprising modifying a genomic fragment of theStreptococcus, wherein the genomic fragment comprises at least a functional part of a fragment identifiable by hybridization inStreptococcus suisto a nucleic acid or fragment thereof.

REFERENCES:
patent: 5610011 (1997-03-01), Smith et al.
patent: 5681570 (1997-10-01), Yang et al.
patent: 5733765 (1998-03-01), Mollet et al.
patent: 5786184 (1998-07-01), Mollet et al.
patent: 5928900 (1999-07-01), Masure et al.
patent: 5948900 (1999-09-01), Yother et al.
patent: 5981229 (1999-11-01), Masure et al.
patent: 7109006 (2006-09-01), Smith
patent: 7125548 (2006-10-01), Smith
patent: 7670835 (2010-03-01), Smith
patent: 2002/0055168 (2002-05-01), Smith
patent: 2007/0111236 (2007-05-01), Smith
patent: 2008/0241181 (2008-10-01), Smith
patent: WO 92/16630 (1992-10-01), None
patent: WO 93/18164 (1993-09-01), None
patent: WO 95/08732 (1995-03-01), None
patent: WO 95/31548 (1995-11-01), None
patent: WO 96/21485 (1996-07-01), None
patent: WO 96/23073 (1996-08-01), None
patent: WO 98/19689 (1998-05-01), None
patent: WO 00/05378 (2000-02-01), None
patent: WO 00/05378 (2000-03-01), None
patent: WO 02/38597 (2002-05-01), None
patent: WO 02/061070 (2002-08-01), None
patent: WO 2009/020391 (2009-02-01), None
1997/1998 Stratagene catalog (p. 118, 1997/1998).
Jadoun, J. et al. Feb. 25, 2000. Mutation in crsR regulator reducesStreptococcus pyogenesinternalization. Microbial Pathogen. 29: 311-317.
Janeway-Travers. 1997. Immunobiology: The Immune System in Health and Disease. 3rd Edition.
Smith et al. 1992. Infection and Immunity. vol. 60(6): 2361-2367.
PCT International Search Report, PCT/NL02/00073, dated Feb. 5, 2003.
PCT International Preliminary Examination Report, PCT/NL03/00073, dated May 7, 2003.
Segers et al., Characterization of the gene encoding suflysin fromStreptococcus suisand expression in field strains, FEMS Microbiology Letters, 1998, pp. 255-261, vol. 167.
Smith et al., Environmentally regulated genes ofStreptococcus suis: identification by the use of iron-restricted conditions in vitro and by experimental infections of piglets,Microbiology, 2001, pp. 271-280, vol. 147.
Smith et al., Identification and characterization of the cps locus ofStreptococcus suisserotype 2: the capsule protects against phagocytosis and is an important virulence factor, Infect Immun., Apr. 1999, pp. 1750-1756, vol. 67, No. 4.
Smith et al., Selection of virulence-associated determinants ofStreptococcus suisserotype 2 by in vivo complementation, Infection and Immunity, Mar. 2001, pp. 1961-1966, vol. 69, No. 3.
Smith et al., Mutants ofStreptococcus suisTypes 1 and 2 Impaired in Expression of Muramidase-Released Protein and Extracellular Protein induce Disease in Newborn Germfree Pigs, Infection and Immunity, Oct. 1996, pp. 4409-4412, vol. 64, No. 10.
Elliott et al., Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptoccoccus suistype 2 with particular reference to vaccination against streptococcal meningitis in pigs, Oct. 1980, pp. 275-285, vol. 85, No. 2.
Roberts et al., The biochemistry and genetics of capsular polysaccharide production in bacteria, Ann. Rev. Microbiol., 1996, pp. 285-315, vol. 50.
Smith et al., High efficiency transformation and gene inactivation inStreptococcus suistype 2, Microbiology, Jan. 1995, pp. 181-188, vol. 141.
Smith et al., Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase released protein) ofStreptococcus suistype 2, Infection and Immunity, 1992, pp. 2361-2367, vol. 60, No. 6.
Smith et al., Repeats in an extracellular protein of weakly pathogenic strains ofStreptococcus suistype 2 are absent in pathogenic strains, Infection and Immunity, 1993, pp. 3318-3326, vol. 61, No. 8.
Smith et al., The cps locus ofStreptococcus suisserotype 2: genetic determinant for the synthesis of sialic acid, Microbial Pathogenesis, 2000, pp. 127-134, vol. 29, No. 2.
Watson et al., Pneumococcal Virulence Factors and Host Immune Responses to Them, European Journal of Clinical Microbiology & Infectious Diseases, Jun. 1995, pp. 479-490, vol. 14, No. 6.
Joh et al., Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells, Matrix Biology, 1999, pp. 211-223, vol. 18.
UniProtKB/TrEMBL entry Q8RP86 (visited Feb. 18, 2009), <http://ww.expasy.org/uniprot/Q8RP86—STRSU>.
EMBL Nucleotide Sequence Entry EMBLCDS:AAL85276 (visited Feb. 18, 2009). <http://srs.ebi.ac.uk.srsbin/cgi-bin/wgetz?-e+[EMBLCDS:AAL85276]+-NEWiD>.
Uniprot Q8RP86 (visited Feb. 18, 2009), <http://www.uniprot.org/uniref/?query=Q8RP86+AND+identity%3A0.5>.
U.S. Appl. No. 11/982,192, filed Oct. 31, 2007, Smith, Environmentally Regulated Genes ofStreptococcus suis.
Dutch Text Annual Report ID-DLOStreptococcus suis, 1996, with English translation of said report.
Office Action for U.S. Appl. No. 11/516,691, dated Oct. 15, 2007.
Office Action for U.S. Appl. No. 11/516,691, dated Feb. 26, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Apr. 22, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Dec. 5, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Jun. 22, 2009.
Office Action for U.S. Appl. No. 11/516,691, dated Nov. 25, 2009.
Notice of Allowance for U.S. Appl. No. 11/516,691, dated Mar. 19, 2010.
Office Action for U.S. Appl. No. 11/982,192, dated May 17, 2010.
Allgaier et al., Relatedness ofStreptococcus suisisolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. Journal of Clinical Microbiology, 2001, pp. 445-453, vol. 39, No. 2.
Busque et al., Immunization of pigs againstStreptococcus suisserotype 2 infection using a live avirulent strain, Can J Vet Res., Oct. 1997, pp. 275-279, vol. 61, No. 4.
Charland et al.,Streptococcus suisserotype 2 mutants deficient in capsular expression, Microbiology, Feb. 1991, pp. 325-332, vol. 144, No. 2.
Database EMBL, ‘Online’ MeNab,S. gordoniipartial aldB gene, cabA gene & fbpA gene, Database accession No. X65164, XP002213089, Sep. 2001.
De Greeff et al., Distribution of Environmentally Regulated Genes ofStreptococcus suisSerotype 2 among 5, suis Serotypes and Other Organisms, Journal of Clinical Microbiology, Sep. 2002, pp. 3261-3268, vol. 40, No. 9.
Elliott et al., Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptococcus suistype 2 with particular reference to vaccination against streptococcal meningitis in pigs, Oct. 1980, pp. 275-285, vol. 85, No. 2.
Kawabata et al., Molecular cloning, sequence and characterization of a novel streptococcal phesphoglycerate dehydrogenase gene, Oral Microbiology and Immunology, 2000, pp. 58-62, vol. 15.
Kolkman et al., Diversity of capsular polysaccharide synthesis gene clusters inStreptococcus pneumoniae, J. Biochem., May 1998, pp. 937-943, vol. 123, No. 5.
Koskiniemi et al., Identification of two genes, cpsX and cpsY, with putative regulatory function on capsule expression in group B streptococci, FEMS Immunology and Medical Microbiology, 1998, pp. 159-168, vol. 21.
McNab, Cloning and sequence analysis of thyridine kinase from the oral bacteriumStreptococcus gordonii, FEMS Microbiology Letters, 1996, pp. 103-110, vol. 135.
Munoz et al., Characterization of ISI515, a Functional Insertion Sequence inStreptococcus pneumoniae, Journal of Bacteriology, Mar. 1998, pp. 1381-1388, vol. 180, No. 6.
Quessy et al., Immunization of mice againstStreptococcus suisserotype 2 infections using a live avirulent strain, Can J. Vet Res., Oct. 1994, pp. 229-301, vol. 58, No. 4.
Baums et al., Clinical and Vaccine Immunology, Feb. 2009, pp. 200-208, vol. 16, No. 2.
Chothia et al., The EMBO Journal, 1986, pp. 823-826, vol. 5, No. 4.
Database EMBL ‘Online’ McNab,S. gordoniipartial aldB gene, csbA gene &#x

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Environmentally regulated genes of Streptococcus suis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Environmentally regulated genes of Streptococcus suis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Environmentally regulated genes of Streptococcus suis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2652857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.